Liste des publications Systemic mastocytosis and bone involvement

Liste des publications
Systemic mastocytosis and bone involvement in a cohort of 75 patients.
Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, Palmerini F, Dubreuil P, Arock M,
Roux C, Launay JM, Fraitag S, Canioni D, Billemont B, Suarez F, Lanternier F, Lortholary
O, Hermine O, Francès C.
Ann Rheum Dis. 2010 Jun 22. [Epub ahead of print]PMID: 20570833 [PubMed - as supplied
by publisher]Related citations
2.
The telomere/telomerase system in autoimmune and systemic immune-mediated diseases.
Georgin-Lavialle S, Aouba A, Mouthon L, Londono-Vallejo JA, Lepelletier Y, Gabet AS,
Hermine O.
Autoimmun Rev. 2010 May 6. [Epub ahead of print]PMID: 20435169 [PubMed - as supplied
by publisher]Related citations
3.
Gastrointestinal involvement and manifestations in systemic mastocytosis.
Sokol H, Georgin-Lavialle S, Grandpeix-Guyodo C, Canioni D, Barete S, Dubreuil P,
Lortholary O, Beaugerie L, Hermine O.
Inflamm Bowel Dis. 2010 Jul;16(7):1247-53.PMID: 20162539 [PubMed - in process]Related
citations
4.
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT
mutations.
Bodemer C, Hermine O, Palmérini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, HadjRabia S, Nasca L, Georgin-Lavialle S, Cohen-Akenine A, Launay JM, Barete S, Feger F,
Arock M, Catteau B, Sans B, Stalder JF, Skowron F, Thomas L, Lorette G, Plantin P,
Bordigoni P, Lortholary O, de Prost Y, Moussy A, Sobol H, Dubreuil P.
J Invest Dermatol. 2010 Mar;130(3):804-15. Epub 2009 Oct 29.PMID: 19865100 [PubMed indexed for MEDLINE]Related citations
5.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Dubreuil P, Letard S, Ciufolini M, Gros L, Humbert M, Castéran N, Borge L, Hajem B,
Lermet A, Sippl W, Voisset E, Arock M, Auclair C, Leventhal PS, Mansfield CD, Moussy A,
Hermine O.
PLoS One. 2009 Sep 30;4(9):e7258.PMID: 19789626 [PubMed - indexed for
MEDLINE]Free PMC ArticleFree textRelated citations
6.
[Mastocytosis and anaesthesia]
Dewachter P, Mouton-Faivre C, Cazalaà JB, Carli P, Lortholary O, Hermine O.
Ann Fr Anesth Reanim. 2009 Jan;28(1):61-73. Epub 2008 Dec 18. Review. French. PMID:
19097849 [PubMed - indexed for MEDLINE]Related citations
7.
Masitinib is safe and effective for the treatment of canine mast cell tumors.
Hahn KA, Ogilvie G, Rusk T, Devauchelle P, Leblanc A, Legendre A, Powers B, Leventhal
PS, Kinet JP, Palmerini F, Dubreuil P, Moussy A, Hermine O.
J Vet Intern Med. 2008 Nov-Dec;22(6):1301-9. Epub 2008 Sep 24. Erratum in: J Vet Intern
Med. 2009 Jan-Feb;23(1):224. Oglivie, G [corrected to Ogilvie, G]. PMID: 18823406
[PubMed - indexed for MEDLINE]Related citations
8.
Mastocytosis is not related to allergic diseases.
Dewachter P, Mouton-Faivre C, Hermine O.
Allergy. 2008 Sep;63(9):1248. No abstract available. PMID: 18699942 [PubMed - indexed
for MEDLINE]Related citations
9.
Gain-of-function mutations in the extracellular domain of KIT are common in canine mast
cell tumors.
Letard S, Yang Y, Hanssens K, Palmérini F, Leventhal PS, Guéry S, Moussy A, Kinet JP,
Hermine O, Dubreuil P.
Mol Cancer Res. 2008 Jul;6(7):1137-45.PMID: 18644978 [PubMed - indexed for
MEDLINE]Free ArticleRelated citations
10.
Case-control cohort study of patients' perceptions of disability in mastocytosis.
Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A,
Palmérini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus
P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A.
PLoS One. 2008 May 28;3(5):e2266.PMID: 18509466 [PubMed - indexed for
MEDLINE]Free PMC ArticleFree textRelated citations
11.
[Current concepts and treatment advances in systemic mastocytosis]
Georgin-Lavialle S, Barete S, Suarez F, Lepelletier Y, Bodemer C, Dubreuil P, Lortholary O,
Hermine O.
Rev Med Interne. 2009 Jan;30(1):25-34. Epub 2008 Apr 10. Review. French. PMID:
18406017 [PubMed - indexed for MEDLINE]Related citations
12.
Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.
Lanternier F, Cohen-Akenine A, Palmerini F, Feger F, Yang Y, Zermati Y, Barète S, Sans B,
Baude C, Ghez D, Suarez F, Delarue R, Casassus P, Bodemer C, Catteau A, Soppelsa F,
Hanssens K, Arock M, Sobol H, Fraitag S, Canioni D, Moussy A, Launay JM, Dubreuil P,
Hermine O, Lortholary O; AFIRMM network.
PLoS One. 2008 Apr 9;3(4):e1906.PMID: 18404201 [PubMed - indexed for MEDLINE]Free
PMC ArticleFree textRelated citations
13.
Thalidomide in advanced mastocytosis.
Damaj G, Bernit E, Ghez D, Claisse JF, Schleinitz N, Harlé JR, Canioni D, Hermine O.
Br J Haematol. 2008 Apr;141(2):249-53. Epub 2008 Feb 26.PMID: 18307561 [PubMed indexed for MEDLINE]Related citations
14.
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment
recommendations and response criteria.
Valent P, Akin C, Escribano L, Födinger M, Hartmann K, Brockow K, Castells M, Sperr WR,
Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K,
Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz
LB, Orfao A, Horny HP, Metcalfe DD.
Eur J Clin Invest. 2007 Jun;37(6):435-53. Review.PMID: 17537151 [PubMed - indexed for
MEDLINE]Related citations
15.
Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells.
Gabillot-Carré M, Lepelletier Y, Humbert M, de Sepuvelda P, Hamouda NB, Zappulla JP,
Liblau R, Ribadeau-Dumas A, Machavoine F, Letard S, Baude C, Hermant A, Yang Y,
Vargaftig J, Bodemer C, Morelon E, Lortholary O, Recher C, Laurent G, Dy M, Arock M,
Dubreuil P, Hermine O.
Blood. 2006 Aug 1;108(3):1065-72. Epub 2006 Apr 4.PMID: 16597595 [PubMed - indexed
for MEDLINE]Free ArticleRelated citations
16.
[Systemic mastocytosis]
Fain O, Stirnemann J, Eclache V, Barete S, Casassus P, Hermine O, Lorholary O.
Presse Med. 2005 May 14;34(9):681-7. Review. French. PMID: 15988348 [PubMed indexed for MEDLINE]Related citations
17.
Interest of interferon alpha in systemic mastocytosis. The French experience and review of the
literature.
Simon J, Lortholary O, Caillat-Vigneron N, Raphaël M, Martin A, Brière J, Barète S,
Hermine O, Casassus P; Group AFIRMM (Association française pour les initiatives de
recherche sur le mastocyte et les mastocytoses).
Pathol Biol (Paris). 2004 Jun;52(5):294-9. Review.PMID: 15217717 [PubMed - indexed for
MEDLINE]Related citations
18.
[Treatment of systemic mastocytosis]
Marrache F, Mémain N, Bonté I, Barete S, Casassus P, de Gennes C, Fain O, Hermine O,
Lortholary O.
Rev Med Interne. 2003 Sep;24(9):594-601. Review. French. PMID: 12951180 [PubMed indexed for MEDLINE]Related citations
19.
Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various
mutated c-kit receptors found in mast cell neoplasms.
Zermati Y, De Sepulveda P, Féger F, Létard S, Kersual J, Castéran N, Gorochov G, Dy M,
Ribadeau Dumas A, Dorgham K, Parizot C, Bieche Y, Vidaud M, Lortholary O, Arock M,
Hermine O, Dubreuil P.
Oncogene. 2003 Feb 6;22(5):660-4.PMID: 12569358 [PubMed - indexed for
MEDLINE]Related citations